🇺🇸 FDA

Intelligence Platform

Patents

Browse 76 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 10080740

Trisubstituted benzotriazole derivatives as dihydroorotate oxygenase inhibitors

Aurigene Discovery Technologies Limited · Granted Tue Sep 25 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9993765

Portable oxygen enrichment device and method of use

SEPARATION DESIGN GROUP LLC · Granted Tue Jun 12 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 07 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9937155

Methods of use for trisubstituted benzotriazole derivatives as dihydroorotate oxygenase in

Aurigene Discovery Technologies Limited · Granted Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9839690

Singlet oxygen-labile linkers and methods of production and use thereof

The Board of Regents of the University of Oklahoma · Granted Tue Dec 12 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9750849

Oxygen generating biomaterial

The Board of Regents of the University of Texas System · Granted Tue Sep 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 31 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9663790

Adipocyte-specific constructs and methods for inhibiting platelet-type 12 lipoxygenase exp

The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center · Granted Tue May 30 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 25 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9630932

Trisubstituted benzotriazole derivatives as dihydroorotate oxygenase inhibitors

Aurigene Discovery Technologies Limited · Granted Tue Apr 25 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9499497

Compounds useful as inhibitors of indoleamine 2,3-dioxygenase

Vertex Pharmaceuticals Incorporated · Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9493526

Compositions and methods for the delivery of oxygen

The Regents of the University of California · Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9492781

Portable oxygen enrichment device and method of use

SEPARATION DESIGN GROUP LLC · Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9433666

Indoleamine 2,3-dioxygenase based immunotherapy

IO Biotech ApS · Granted Tue Sep 06 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9393306

Singlet oxygen-labile linkers and methods of production and use thereof

The Board of Regents of the University of Oklahoma · Granted Tue Jul 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9114151

Method for modulating or controlling sodium channel current by reactive oxygen species (RO

THE UNITED STATES OF AMERICA DEPT. OF VETERANS AFFAIRS · Granted Tue Aug 25 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 20 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9073875

Compounds useful as inhibitors of indoleamine 2,3-dioxygenase

Vertex Pharmaceuticals Incorporated · Granted Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9018210

Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenat

The Regents of the University of California · Granted Tue Apr 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8888902

Portable oxygen enrichment device and method of use

SEPARATION DESIGN GROUP LLC · Granted Tue Nov 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8883189

Intraocular encapsulation of oxygenic bacteria

The Regents of the University of Colorado, a Body Corporate · Granted Tue Nov 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8841295

5-lipoxygenase-activating protein (FLAP) inhibitors

Panmira Pharmaceuticals, LLC · Granted Tue Sep 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8772495

5-lipoxygenase-activating protein inhibitor

Panmira Pharmaceuticals, LLC · Granted Tue Jul 08 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8710081

5-lipoxygenase-activating protein (FLAP) inhibitors

Panmira Pharmaceuticals, LLC · Granted Tue Apr 29 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8697730

5-lipoxygenase activating protein (FLAP) inhibitor

Panmira Pharmaceuticals, LLC · Granted Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8580844

Use of inhibitors of indoleamine-2,3-dioxygenase in combination with other therapeutic mod

Georgia Regents Research Institute, Inc. · Granted Tue Nov 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8455437

Method to predict and prevent oxygen-induced inflammatory tissue injury

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jun 04 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 30 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8404631

Compositions and methods for the delivery of oxygen

The Regents of the University of California · Granted Tue Mar 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted